EXONEURAL MEDICINE PLATFORM
Dead / Abandoned — Abandoned — failure to respond (as of 06 Jun 2022)
What this means for you
This application is over — abandoned 23 May 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88651546
- Mark type
- Stylized text
- Filed
- 11 Oct 2019
- Published for opposition
- 25 Feb 2020
- Abandoned
- 23 May 2022
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals
Owner
- Cygnal Therapeutics, Inc., Cambridge, MA, US
- Cygnal Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 06 Jun 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 06 Jun 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 06 Jun 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 22 Nov 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 22 Nov 2021 — FINAL REFUSAL E-MAILED
- 22 Nov 2021 — SU - FINAL REFUSAL - WRITTEN
- 16 Nov 2021 — ASSIGNED TO EXAMINER
- 13 Oct 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Oct 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Oct 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Jun 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Jun 2021 — NON-FINAL ACTION E-MAILED
- 01 Jun 2021 — SU - NON-FINAL ACTION - WRITTEN
- 06 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Apr 2021 — USE AMENDMENT FILED